Legacy Bridge LLC Sells 130 Shares of CME Group Inc. (NASDAQ:CME)

Posted by Renee Jackson on Mar 19th, 2023

Legacy Bridge LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 5.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,338 shares of the financial services provider’s stock after selling 130 shares during the quarter. Legacy Bridge LLC’s holdings in CME Group were worth $393,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in CME Group by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 32,767,510 shares of the financial services provider’s stock worth $5,804,109,000 after acquiring an additional 429,912 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in CME Group by 0.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock worth $1,224,597,000 after acquiring an additional 31,354 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its holdings in CME Group by 1.1% during the 2nd quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,195,042 shares of the financial services provider’s stock worth $858,725,000 after acquiring an additional 44,252 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in CME Group by 10.3% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,732,293 shares of the financial services provider’s stock worth $764,000,000 after acquiring an additional 349,520 shares during the last quarter. Finally, Amundi grew its holdings in CME Group by 0.9% during the 2nd quarter. Amundi now owns 2,633,574 shares of the financial services provider’s stock worth $525,475,000 after acquiring an additional 23,261 shares during the last quarter. 85.09% of the stock is owned by institutional investors.

CME Group Stock Down 0.7 %

CME Group stock opened at $185.98 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.13. The firm’s fifty day moving average is $180.83 and its 200 day moving average is $178.75. CME Group Inc. has a 12-month low of $166.54 and a 12-month high of $251.99. The company has a market capitalization of $66.90 billion, a PE ratio of 25.17, a PEG ratio of 3.63 and a beta of 0.41.

CME Group (NASDAQ:CME – Get Rating) last released its quarterly earnings data on Wednesday, February 8th. The financial services provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.02. CME Group had a net margin of 53.61% and a return on equity of 10.43%. The firm had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter in the prior year, the company posted $1.66 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 8.46 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 27th. Stockholders of record on Friday, March 10th will be paid a $1.10 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend is Thursday, March 9th. This represents a $4.40 annualized dividend and a dividend yield of 2.37%. CME Group’s dividend payout ratio is presently 59.54%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of analyst reports. UBS Group reduced their price objective on shares of CME Group from $226.00 to $220.00 in a research note on Thursday, January 5th. Citigroup reduced their price objective on shares of CME Group from $214.29 to $210.00 in a research note on Thursday, January 12th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $161.00 price objective on shares of CME Group in a research note on Thursday, February 9th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $200.00 to $218.00 in a research note on Thursday, February 9th. Finally, Credit Suisse Group upped their price objective on shares of CME Group from $192.00 to $198.00 and gave the company an “outperform” rating in a research note on Tuesday, February 7th. One research analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $219.83.

About CME Group

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.